41736-92-9

Basic information

• Product Name: N-Hexadecanoyl-4-hydroxy-L-proline
• Synonyms: N-HEXADECANOYL-HYDROXYPROLINE;N-HEXADECANOYL-4-HYDROXY-L-PROLINE;(4R)-4-Hydroxy-1-palmitoyl-L-proline
• CAS NO: 41736-92-9
• Molecular Formula: C21H39NO4
• Molecular Weight: 369.54
• Mol File: 41736-92-9.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 548.1 °C at 760 mmHg
• Flash Point: 285.3 °C
• Appearance: /
• Density: 1.051
• Refractive Index: 1.502
• CAS DataBase Reference: N-Hexadecanoyl-4-hydroxy-L-proline(CAS DataBase Reference)
• NIST Chemistry Reference: N-Hexadecanoyl-4-hydroxy-L-proline(41736-92-9)
• EPA Substance Registry System: N-Hexadecanoyl-4-hydroxy-L-proline(41736-92-9)

Safety Data

• Hazardous Substances Data: 41736-92-9(Hazardous Substances Data)

Usage

General Description

N-Hexadecanoyl-4-hydroxy-L-proline is a chemical compound that belongs to the class of fatty acid derivatives and amino acids. It is composed of a hexadecanoic acid (palmitic acid) molecule attached to a 4-hydroxy-L-proline amino acid. N-Hexadecanoyl-4-hydroxy-L-proline has shown potential as an anti-inflammatory and antioxidant agent, and it is being studied for its potential use in skincare products due to its moisturizing and anti-aging properties. Additionally, N-Hexadecanoyl-4-hydroxy-L-proline has shown promise as a potential therapeutic agent for the treatment of inflammatory conditions and skin disorders. Further research is needed to fully understand its mechanism of action and potential applications.

InChI:InChI=1/C21H39NO4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20(24)22-17-18(23)16-19(22)21(25)26/h18-19,23H,2-17H2,1H3,(H,25,26)/t18?,19-/m0/s1

Upstream product

• 1492-30-4 4-nitrophenyl palmitate 
• 51-35-4 4-hydroxyproline 
• 57-10-3 1-hexadecylcarboxylic acid 

Relevant articles and documents

Biodegradable copolyester of 4-hydroxy proline and pharmaceutical composition containing the same

A biodegradable copolymer having the constituent units derived from 4-hydroxyproline and an aliphatic α-hydroxycarboxylic acid, represented by the structures (I) and (II): wherein X represents a hydrogen atom, an acyl group having the formula RCO- where R is a hydrocarbon or an alkoxy group having 1 to 20 carbon atoms, and Y represents a hydrogen atom or an alkyl group having 1 to 8 carbon atoms, and m and n are independently integers of 1 or more, m + n is at least 10, and m/(m + n) is at least 0.01 and a pharmaceutical composition containing the same.